78 related articles for article (PubMed ID: 8590986)
1. Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP3 receptor.
Nakagawa T; Minami M; Katsumata S; Ienaga Y; Satoh M
Br J Pharmacol; 1995 Nov; 116(6):2661-6. PubMed ID: 8590986
[TBL] [Abstract][Full Text] [Related]
2. Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence.
Walker EA; Sterious SN
Br J Pharmacol; 2005 Aug; 145(7):975-83. PubMed ID: 15912139
[TBL] [Abstract][Full Text] [Related]
3. The antidepressant agomelatine attenuates morphine-induced reinstatement but not self-administration or precipitated withdrawal.
De A; Grasing KW
Pharmacol Biochem Behav; 2023 Feb; 223():173525. PubMed ID: 36758685
[TBL] [Abstract][Full Text] [Related]
4. Teneurin C-terminal associated peptide (TCAP)-1 attenuates the development and expression of naloxone-precipitated morphine withdrawal in male Swiss Webster mice.
Mueller LE; Wexler RS; Lovejoy DA; Stein RB; Slee AM
Psychopharmacology (Berl); 2024 Apr; ():. PubMed ID: 38630316
[TBL] [Abstract][Full Text] [Related]
5. Model of negative affect induced by withdrawal from acute and chronic morphine administration in male mice.
Ozdemir D; Meyer J; Kieffer BL; Darcq E
Sci Rep; 2024 Apr; 14(1):9767. PubMed ID: 38684914
[TBL] [Abstract][Full Text] [Related]
6. Memantine and SKF82958 but not an enriched environment modulate naloxone-precipitated morphine abstinence syndrome without affecting hippocampal tPA mRNA levels in rats.
Aslan A; Hatırnaz-Ng Ö; Taşar O; Özbek U; Yamantürk-Çelik P
Pharmacol Biochem Behav; 2024 Jan; 234():173688. PubMed ID: 38056696
[TBL] [Abstract][Full Text] [Related]
7. Validation and characterization of oxycodone physical dependence in C57BL/6J mice.
Carper M; Contreras KM; Walentiny DM; Beardsley PM; Damaj MI
Eur J Pharmacol; 2021 Jul; 903():174111. PubMed ID: 33901461
[TBL] [Abstract][Full Text] [Related]
8. Effects of inhaled low-concentration xenon gas on naltrexone-precipitated withdrawal symptoms in morphine-dependent mice.
Kaufman MJ; Meloni EG; Qrareya AN; Paronis CA; Bogin V
Drug Alcohol Depend; 2024 Feb; 255():110967. PubMed ID: 38150894
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic profile of ITI-333: a novel molecule for treatment of substance use disorders.
Snyder GL; Li P; Martin T; Zhang L; Yao W; Zheng H; Maguire DR; Gerak LR; Vanover KE; France CP; Davis R
Psychopharmacology (Berl); 2024 Jul; 241(7):1477-1490. PubMed ID: 38710856
[TBL] [Abstract][Full Text] [Related]
10. Cannabidiol Reduced the Severity of Gastrointestinal Symptoms of Opioid Withdrawal in Male and Female Mice.
Scicluna RL; Wilson BB; Thelaus SH; Arnold JC; McGregor IS; Bowen MT
Cannabis Cannabinoid Res; 2024 Apr; 9(2):547-560. PubMed ID: 36577048
[No Abstract] [Full Text] [Related]
11. Xylazine suppresses fentanyl consumption during self-administration and induces a unique sex-specific withdrawal syndrome that is not altered by naloxone in rats.
Khatri SN; Sadek S; Kendrick PT; Bondy EO; Hong M; Pauss S; Luo D; Prisinzano TE; Dunn KE; Marusich JA; Beckmann JS; Hinds TD; Gipson CD
Exp Clin Psychopharmacol; 2024 Apr; 32(2):150-157. PubMed ID: 37470999
[TBL] [Abstract][Full Text] [Related]
12. A survey of acute and chronic heroin dependence in ten inbred mouse strains: evidence of genetic correlation with morphine dependence.
Klein G; Juni A; Waxman AR; Arout CA; Inturrisi CE; Kest B
Pharmacol Biochem Behav; 2008 Sep; 90(3):447-52. PubMed ID: 18472145
[TBL] [Abstract][Full Text] [Related]
13. L-cysteine ethyl ester prevents and reverses acquired physical dependence on morphine in male Sprague Dawley rats.
Bates JN; Getsy PM; Coffee GA; Baby SM; MacFarlane PM; Hsieh YH; Knauss ZT; Bubier JA; Mueller D; Lewis SJ
Front Pharmacol; 2023; 14():1303207. PubMed ID: 38111383
[TBL] [Abstract][Full Text] [Related]
14. Effects of CB1 receptor negative allosteric modulator Org27569 on oxycodone withdrawal symptoms in mice.
Scicluna RL; Everett NA; Badolato CJ; Wilson BB; Bowen MT
Psychopharmacology (Berl); 2024 Apr; ():. PubMed ID: 38676755
[TBL] [Abstract][Full Text] [Related]
15. Astroglial Knockout of Glucocorticoid Receptor Attenuates Morphine Withdrawal Symptoms, but Not Antinociception and Tolerance in Mice.
Tertil M; Skupio U; Kudla L; Wiktorowska L; Przewlocki R
Cell Mol Neurobiol; 2022 Oct; 42(7):2423-2426. PubMed ID: 33821329
[TBL] [Abstract][Full Text] [Related]
16. Structures of human prostaglandin F
Lv X; Gao K; Nie J; Zhang X; Zhang S; Ren Y; Sun X; Li Q; Huang J; Liu L; Zhang X; Zhang W; Liu X
Nat Commun; 2023 Dec; 14(1):8136. PubMed ID: 38065938
[TBL] [Abstract][Full Text] [Related]
17. Operational definition of precipitated opioid withdrawal.
Dunn KE; Bird HE; Bergeria CL; Ware OD; Strain EC; Huhn AS
Front Psychiatry; 2023; 14():1141980. PubMed ID: 37151972
[TBL] [Abstract][Full Text] [Related]
18. Comparing withdrawal- and anxiety-like behaviors following oral and subcutaneous oxycodone administration in C57BL/6 mice.
De Almeida SS; Drinkuth CR; Sartor GC
Behav Pharmacol; 2024 Jun; ():. PubMed ID: 38847447
[TBL] [Abstract][Full Text] [Related]
19. Fragile-like regulatory T cells modulate opioid withdrawal in humans and mice.
Mikati MO; Klein RS
Immunity; 2023 Feb; 56(2):237-239. PubMed ID: 36792570
[TBL] [Abstract][Full Text] [Related]
20. Frequent jumps from human hosts.
Moi D; Dessimoz C
Nat Ecol Evol; 2024 May; 8(5):854-855. PubMed ID: 38528190
[No Abstract] [Full Text] [Related]
[Next] [New Search]
